These results show that in various logistic regression models, serum neurofilament light chain was associated with both 1-year disease progression and therapy response during follow-up in chronic inflammatory demyelinating polyneuropathy. The gene discussed is NEFL; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.